Viral vector manufacturing market was valued at USD 254.54 million in 2018, at a CAGR of 9.2% during the forecast period 2019-2026.
Increasing prevalence of chronic diseases and targeted diseases are driving the demand for gene therapy. During viral vector transmission, it is ensured that the viral particle is not infectious. Today, retrovirus adenovirus, adeno-associated virus, and lentivirus are most commonly used as a ... Read more
The global viral vector manufacturing market is expected to exhibit a strong 22.65%CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The nreport forecasts a valuation of USD 319 million for the market by the end of the 2018-2023 forecast period. The report takes a close look at historical factors enabling ... Read more
